jueves, 5 de enero de 2012

Journal of Translational Medicine

open here please:
Journal of Translational Medicine

  • Research
    Open Access

    Effects of adjuvants on IgG subclasses elicited by Virus-Like Particles

    Visciano ML, Tagliamonte M, Tornesello ML, Buonaguro FM and Buonaguro L Journal of Translational Medicine 2012, 10:4 (5 January 2012)

  • Review
    Open Access

    Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients

    Patil SS, Gentschev I, Nolte I, Ogilvie G and Szalay AA Journal of Translational Medicine 2012, 10:3 (4 January 2012)

  • Research
    Open Access

    Preventing Intimal Thickening of Vein Grafts in Vein Artery Bypass Using STAT-3 siRNA

    Sun J, Zheng J, Ling KH, Zhao K, Xie Z, Li B, Wang T, Zhu Z et al. Journal of Translational Medicine 2012, 10:2 (4 January 2012)

  • Editorial
    Open Access

    The Immune Score as a New Possible Approach for the Classification of Cancer

    Galon J, Pages F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF and Ascierto PA Journal of Translational Medicine 2012, 10:1 (3 January 2012)

  • Research
    Open Access

    Poly I:C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials

    Fucikova J, Rozkova D, Ulcova H, Budinsky V, Sochorova K, Pokorna K, Bartunkova J and Spisek R Journal of Translational Medicine 2011, 9:223 (30 December 2011)

  • Review
    Open Access

    Genomic Sequencing in Clinical Trials

    Mestan KK, Ilkhanoff L, Mouli S and Lin S Journal of Translational Medicine 2011, 9:222 (30 December 2011)

  • Research
    Open Access

    Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors

    Spugnini EP, Baldi A, Buglioni S, Carocci F, Milesi de Bazzichini G, Betti G, Pantaleo I, Menicagli F et al. Journal of Translational Medicine 2011, 9:221 (28 December 2011)

  • Research
    Open Access

    High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma

    Wang X, Zhang L, Goldberg SN, Bhasin M, Brown V, Alsop DC, Signoretti S, Mier JW et al. Journal of Translational Medicine 2011, 9:220 (21 December 2011)
  • No hay comentarios:

    Publicar un comentario